Selkoe Dennis J.

Avg. Two Year Performance

No purchase track record

26% Avg. Sale Return

12% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	4%	2%	(< 1%)	22%	26%
Sale Success Rate	8 of 12	6 of 12	7 of 12	8 of 12	5 of 12

Prothena Corporation plc

Drugs » Biotechnology

Director:

Holdings: 4.21K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--